T-CURE BIOSCIENCES

t-cure-biosciences-logo

T-Cure Biosciences is a Biotechnology Company.

#SimilarOrganizations #People #Website #More

T-CURE BIOSCIENCES

Social Links:

Industry:
Biotechnology

Founded:
2016-01-01

Address:
Sherman Oaks, California, United States

Country:
United States

Website Url:
http://www.t-cure.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
Google Maps U.S. Server Location Google Maps API


Similar Organizations

not_available_image

Aldebaran Therapeutics

Aldebaran Therapeutics is a biotechnology company.

geneius-logo

Geneius

Geneius is a Biotechnology company.

not_available_image

IBT Vaccines

IBT Vaccines is a biotechnology company.

not_available_image

Sanford Biosciences

Sanford Biosciences is a biotech company.

not_available_image

Subintro

Subintro is a biotechnology company.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

Current Employees Featured

gang-zeng_image

Gang Zeng
Gang Zeng President and CEO @ T-Cure Biosciences
President and CEO
2016-10-01

Founder


gang-zeng_image

Gang Zeng

Official Site Inspections

http://www.t-cure.com

  • Host name: box5934.bluehost.com
  • IP address: 50.116.65.110
  • Location: Burlington United States
  • Latitude: 42.509
  • Longitude: -71.1984
  • Metro Code: 506
  • Timezone: America/New_York
  • Postal: 01803

Loading ...

More informations about "T-Cure Biosciences"

T-Cure Biosciences - Crunchbase Company Profile & Funding

T Cell Receptor (TCR) Therapy: A therapy involving the engineering of T cells with TCRs to target and destroy solid tumors by recognizing specific intracellular or cell-surface targets. iSORT …See details»

T-Cure Bioscience - VentureRadar

"T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies …See details»

About - T Cure Bioscience

T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies …See details»

T-Cure Bioscience, Inc - LinkedIn

T-Cure Bioscience, Inc | 967 followers on LinkedIn. Committed to delivering effective TCR cancer therapies. Striving towards a cure. | Founded by early pioneers of T cell receptor (TCR) …See details»

T-Cure Biosciences - The Org

Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find the cure for human cancer using its cutting-edge TCR-T technologies. Using its proprietary iSORT TCR …See details»

T-Cure Bioscience, Inc Overview | SignalHire Company Profile

Organization Website: t-cure.com : T-Cure Bioscience, Inc industries Biotech: Headquarters Location: Sherman Oaks, CA, 91411 US Sherman Oaks, CA, 91411 US : T-Cure Bioscience, …See details»

T-Cure Bioscience, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for T-Cure Bioscience, Inc. of Van Nuys, CA. Get the latest business insights from Dun & Bradstreet.See details»

T-Cure Bioscience, Inc. - Drug pipelines, Patents, Clinical trials ...

T-Cure Bioscience, Inc. is a privately-owned corporation headquartered in Sherman Oaks, California, which operates in the field of clinical-stage immuno-oncology. ... The statistics for …See details»

T-Cure Bioscience | Qualifyze

T-Cure is an emerging company in the field of immuno-oncology, focusing on the development of advanced T cell therapies for individuals suffering from solid tumors. The organization is …See details»

Gang Zeng - President and CEO @ T-Cure Biosciences - Crunchbase

Primary Organization . T-Cure Biosciences . Location Greater Los Angeles Area, California, United States; Regions West Coast, Western US; Gender Male; ... Gang Zeng has 2 current …See details»

T-Cure Bioscience - BIO Investor Forum | BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... T-Cure Bioscience, Inc. is an …See details»

T-Cure Biosciences - Contacts, Employees, Board Members

Organization. T-Cure Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 4. ... T-Cure …See details»

Management - T Cure Bioscience

Director Human Resources and Administration Chrystal Torry. Chrystal Torry has over 10 years of experience in Human Resource Management. As a seasoned Human Resources leader and …See details»

T-Cure - Biotech Careers

T-Cure is committed to delivering effective and durable cell therapies for the treatment of cancer. They are developing an new generation of clinical-stage T cell receptor (TCR) therapies to …See details»

T-Cure Bioscience Enters Into Agreement With Rutgers to Conduct ...

Mar 17, 2021 T-Cure anticipates the KK-LC-1 TCR therapy will enter a multi-site Phase 1 clinical study in the second quarter of 2021 at the NCI, with the clinical study responsibilities to be …See details»

T-Cure Bioscience Signs Exclusive Worldwide License

Apr 8, 2020 About T-Cure Bioscience, Inc. T-Cure Bioscience, Inc. is an innovative immuno-oncology company committed to delivering effective and durable cell therapies for the …See details»

Finding T-Cure: A CEO's vision for the future of adoptive cell ...

Mar 31, 2020 At T-Cure, we have developed a platform technology called iSORT that isolate TCRs against a wider range of antigens, not only NY-ESO-1, which could be considered a safe target, the platform can also isolate TCRs against a large variety of targets. For each antigen we have developed a suite that contains TCRs against a specific Antigen ...See details»

News - T Cure Bioscience

August 04, 2020 – T-Cure Bioscience Announces Expansion of Collaboration With the National Institutes of Health for T Cell Receptor (TCR) Therapy Targeting HERV-E for the Treatment of …See details»

WO2022192701 - Drug Targets, Indications, Patents - Synapse

WO2022192701, Initially developed by T-Cure Bioscience, Inc., Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms, Active Indication ...See details»

linkstock.net © 2022. All rights reserved